ARMISTICE CAPITAL, LLC purchased 11.3% of their position (450K shares) of AVALO THERAPEUTICS, INC. on the open market
Open‑market purchases signal personal conviction — classified as a moderate purchase.
P · 1 purchase
Filed: 2/9/2023ACC: 0000899243-23-004412
Director10% Owner
Since Jun 2018
+900.33K
Net shares
Net buyer
$1.3K
Total acquired
1
Open market trades
1B · 0S
3
Total transactions
900.33K acquired
Non-Derivative Transactions2
Common Stock
Indirect
Shares
+334.00
Price / share
$3.95
Trade value
$1.32K
% of position
0.0%
2/3/2023
3.96M→3.96M
Common Stock
Indirect
Shares
+450K
Price / share
—
Trade value
—
% of position
11.3%
2/7/2023
3.96M→4.42M
Total
Net shares
+450.33K
Net value
$1.32K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 2/3/2023 | L · L | +334.00 | $3.95 | $1.32K | 0.0% | 3.96M | 3.96M |
| Common Stock Indirect | 2/7/2023 | P · Purchase | +450K | — | — | 11.3% | 3.96M | 4.42M |
| Total | +450.33K | $1.32K | ||||||
Derivative Transactions1
Warrant
Indirect
Converts to
Common Stock
450K shares
Shares
+450K
Strike price
5.00
Held after
450K
Exercisable
—
2/7/2023
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Warrant Indirect | Common Stock450K shares | 2/7/2023 | P · Purchase | +450K | 5.00 | — | 450K |
Non-Derivative Holdings (Post-Transaction)1
Common Stock
DirectShares owned34.37K
Total
34.37K direct34.37K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 34.37K | Direct |
| Total | 34.37K | 34.37K direct |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported